As speaker of the board of directors of the German Center for Diabetes Research (DZD) and director of the Institute of Experimental Genetics at Helmholtz Zentrum München, Professor Hrabě de Angelis received an honorary doctorate for his scientific achievements in the field of functional genomics and the resulting elucidation of the molecular factors of human diseases. At the award ceremony, Professor Ingo Autenrieth, dean of the Faculty of Medicine, also lauded Hrabě de Angelis’ extraordinary commitment to the advancement of diabetes research in Tübingen: Since 2009, Tübingen has been one of the five partners of the DZD. During his address Professor Autenrieth said: “As speaker of the board of directors of the DZD, Professor Hrabě de Angelis has made a major contribution to the success of the center. Furthermore, he is the initiator of the interdisciplinary research group “Translational Diabetology”, in which scientists from Tübingen and Munich have been conducting joint research for four years. This is the nucleus of the cooperation between the Tübingen Institute for Diabetes Research and Metabolic Diseases and Helmholtz Zentrum München, which has been successful on many levels. This extraordinary collaborative structure has a model character even within the DZD.”
 
Prof. Dr. Martin Hrabě de Angelis studied biology and sports science for the teaching profession at the University of Marburg before subsequently opting for a scientific career. After completing his doctorate, he worked as a postdoctoral researcher at Jackson Laboratory in Bar Harbor, Maine, USA. Today, in addition to his position at Helmholtz Zentrum München, he also holds the Chair of Experimental Genetics at Technische Universität München.